. The report provides value, in millions of US dollars and volume (in units) within market categories - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Clot Management Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves.
Cryoablation catheters exhibit greater level of efficiency and safety in the treatment of arrhythmias, particularly in perinodal procedures, and thus, are seeing an adoption upsurge. Further, the need to achieve better clinical outcomes in treating a majority of arrhythmias and certain types of structural heart diseases is bolstering the adoption of advanced ablation devices.
The market is driven by several factors, such as the capability to produce customized devices that develops patient outcomes and satisfaction, which led to a growing demand for personalized healthcare solutions. In addition, 3D printing can decrease costs and production time related to traditional manufacturing processes, making it a great option for medical device manufacturers.
The escalating incidences of cardiovascular diseases (CVDs), owing to the sedentary consumer lifestyles and unhealthy dietary patterns and habits, including smoking and alcohol consumption, are primarily driving the cardiovascular devices market. Besides this, the expanding geriatric population, who are more susceptible to chronic heart ailments, is further catalyzing the market growth Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/cardiovascular-devices-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The Thrombectomy Devices in healthcare market was valued at US$ 1,282.07 million in 2018 and it is projected to reach US$ 2,101.29 million by 2027; it is expected to grow at a CAGR of 5.9% from 2019 to 2027.
The ECG telemetry devices market is expected to reach US$ 3,783.48 million by 2028 from US$ 2,087.66 million in 2020; it is estimated to grow at a CAGR of 7.8% during 2021–2028.
The cardiovascular devices market size is expected to reach $60 Billion by 2022, significantly growing at a CAGR of around 2.5% during the forecast period.
The arrythmia monitoring devices market is projected to reach US$ 9,742.95 million by 2028 from US$ 6,212.59 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.
According to our new market research study on “Medical Devices Market to 2027 – Global Analysis and Forecast – by Product Type, Function, and End User,” the market is expected to reach US$ 767,684.9 million by 2027 from US$ 483,285.8 million in 2019; it is estimated to grow at a CAGR of 6.1% from 2020 to 2027. The report highlights trends prevailing in the global medical devices Market and the drivers and restraints pertaining to the market growth.
According to the latest research report by IMARC Group, The global ablation devices market size reached US$ 5.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. More Info:- https://www.imarcgroup.com/ablation-devices-market
The cardiovascular devices market is expected to grow from US$ 48,106.47 million in 2021 to US$ 76,526.68 million in 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028.
The remote patient monitoring devices market accounted to US$ 712.21 Mn in 2018 and is expected to grow at a CAGR of 9.3% during the forecast period 2019 - 2027, to account to US$ 1,544.94 Mn by 2027.
Looking forward, the atherectomy devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/atherectomy-devices-market
Reprocessed Medical Devices Market 2018-2024: This research reviews the overall reprocessed medical devices industry, which according to a report by Global Market Insights, Inc., is growing at more than 14% CAGR during 2017 and 2024 to hit the $3bn revenue mark.
Heart valves are essential for a steady flow of the blood in the right direction into the body. Heart valves are the ones responsible for the constant flow of blood by retaining of the blood pressure. If they don’t function properly, interruption of into the heart procures building a condition called stenosis. Heart diseases generally covering a array of conditions affecting the heart significantly. The regulation of cardiac valves has risen extensively over the last ten years because of the growing patient populace afflicting from cardiovascular diseases.
Embolic Protection Devices Market 2018-2024: This research reviews the overall embolic protection devices industry, which according to a report by Global Market Insights, Inc., is growing at more than 10% CAGR during 2017 and 2024 to hit the $1.8bn revenue mark.
Ligation devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1.38 billion by 2027 growing at a CAGR of 6.38% in the above-mentioned forecast period. Increasing number of gastrointestinal and gynaecological procedures is expected to create new opportunity for the market.
Anastomosis is an operational link between two tubular structures, such as blood vessels or intestinal loops. Anastomosis devices are widely used during the gastrointestinal and cardiac surgeries. Some of the common types of the anastomosis devices are surgical staplers, surgical sutures, and surgical sealants & adhesives.
Global Image Guided Surgery Devices Market is estimated to reach $5.4 billion by 2024; growing at a CAGR of 6.4% from 2016 to 2024. Image guided surgery devices, also known as surgical navigation devices, are used in any surgical procedure by providing accurate treatment guidance and ensure safety of vital structures.
According to The Insight Partners market research study of ‘Clinical Trial Supplies Market to 2027 – Global Analysis and Forecasts by Product & Service, Stage, Drug Type, and Application.’ The global clinical trial supplies market is expected to reach US$ 3,298.91 Mn in 2027 from US$ 1,867.44 Mn in 2019. The market is estimated to grow with a CAGR of 7.4% from 2020-2027. The report provides trends prevailing in the global clinical trial supplies market and the factors driving market along with those that act as hindrances.
Chronic Kidney Disease (CKD) is also termed as chronic kidney failure which is characterized by gradual loss of kidney function. There are various types of medications available in market. Medicines cannot reverse chronic kidney disease, but they are used to treat complications and to slow further kidney damage.
Transcatheter mitral valve repair devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 2661.52 Million by 2027 growing at a CAGR of 21.10% in the above-mentioned forecast period. The growth of transcatheter mitral valve repair devices market is growing due to the increasing prevalence of the mitral valve disorders.
This study forecasts that the global branded generics market revenue is likely to grow more than double by 2030. The current scenario is such that “Generic” names are more popular than the branded ones. For instance – “Amoxicillin” is a well-known drug to treat bacterial infections. However, it’s not “branded” by any means. The “branded” name is “Trimox”.
The global cardiovascular devices market size is prognosticated to reach USD 82.20 billion by 2026 on account of the increasing cases of cardiovascular diseases
The global vascular closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
According to the latest research report by IMARC Group, The Latin America implantable medical devices market size reached US$ 7.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.94% during 2024-2032. More Info:- https://www.imarcgroup.com/latin-america-implantable-medical-devices-market
Reprocessing is a regulated activity for manufacturing the medical devices that are conducted by third party or hospitals. To read more: https://www.goldsteinresearch.com/report/global-reprocessed-medical-devices-market
According to the latest research report by IMARC Group, The global interventional cardiology devices market size reached US$ 21.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028. More Info:- https://www.imarcgroup.com/interventional-cardiology-devices-market
Global Image Guided Surgery Devices Market is estimated to reach $5.4 billion by 2024; growing at a CAGR of 6.4% from 2016 to 2024. Image guided surgery devices, also known as surgical navigation devices, are used in any surgical procedure by providing accurate treatment guidance and ensure safety of vital structures.
The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/real-world-evidence-solutions-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
According to the latest research report by IMARC Group, The global guidewires market is expected to exhibit a growth rate (CAGR) of 4% during 2023-2028. More Info:- https://www.imarcgroup.com/guidewires-market
The global Cardiovascular Application market is estimated to garner a revenue of ~USD 92 billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
According to the latest research report by IMARC Group, The global adhesion barriers market size reached US$ 979.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,472.9 Million by 2028, exhibiting a growth rate (CAGR) of 7% during 2023-2028. More Info:- https://www.imarcgroup.com/adhesion-barriers-market
According to the latest research report by IMARC Group, The global adhesion barriers market size reached US$ 979.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,472.9 Million by 2028, exhibiting a growth rate (CAGR) of 7% during 2023-2028. More Info:- https://www.imarcgroup.com/adhesion-barriers-market
The monopolar electrosurgery Market was valued at USD 3.15 billion in 2022 and is expected to reach USD 4.65 billion in 2032 registering a CAGR of 5% during the forecast period.
The system facilitates scientific advancement, decision support, and scientific advancement in the field of cardiovascular study. Data Bridge Market Research analyses that cardiovascular information systems market is expected to grow with a CAGR of 8.4% during the forecast period.
According to the latest research report by IMARC Group, The global wearable injectors market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion by 2028, exhibiting a growth rate (CAGR) of 14.8% during 2023-2028. More Info:- https://www.imarcgroup.com/wearable-injectors-market
The active implantable medical devices market accounted to US$ 39,026.9 Mn in 2017 and is expected to grow at a CAGR of 7.9% during the forecast period 2018 - 2025, to account to US$ 22,096.9 Mn by 2025.
The Medical Device Technology Market value for was USD 495.26 billion in 2022 and is expected to reach USD 718.92 billion in 2032 growing at a CAGR of 8% during the forecast period. The size of the Medical Device Technology Market was estimated at USD 456.5 billion in 2021 and is projected to grow at a rate of 5.8% over the following five years. The demand for sophisticated medical technologies, the development of chronic diseases, and the ageing of the population are the main drivers of market revenue growth.
According to the latest research report by IMARC Group, The global medical device coatings market size reached US$ 8.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.62% during 2023-2028. More Info:- https://www.imarcgroup.com/medical-device-coatings-market
Looking forward, the capnography devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/capnography-devices-market
Stay up-to-date with latest Insights of mHealth market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
The system facilitates scientific advancement, decision support, and scientific advancement in the field of cardiovascular study. Data Bridge Market Research analyses that cardiovascular information systems market is expected to grow with a CAGR of 8.4% during the forecast period.
Boston Scientific Corporation, IPG Photonics Corporation, Lumenis Ltd., Coherent Inc., Biolitec AG, Hologic Inc., Alma Lasers Ltd., Fotona D.D, Danaher Corporation and Thermo Fisher Scientific Inc. are some prominent laser therapy devices manufacturers as profiled by FMI’s report. New product launches, capacity expansion initiatives and securing regulatory approvals for specific techniques are some key growth strategies.
Hemodynamic monitoring equipment is the type of equipment which helps in inspecting the quality of life, longetivity and cardiovascular health conditions of patients. These factors can be measured using different equipments such as pressure transducing equipment, electrical, invasive & non-invasive and photometric devices. These equipments also consists of different intravascular catheters.
Molecular imaging technology is largely used for classification and measurement of biological processes at the cellular and molecular level with the help of imaging detectors. Molecular imaging presents more modified approach to assessment and organization of cardiovascular disease conditions.
The global external pacemaker market is estimated to garner a revenue of USD 1809.94 Million by the end of 2028 by growing at a CAGR of 7.22% over the forecast period, i.e., 2021 – 2028. Moreover, in the year 2018, the market registered a revenue of USD 899.15 Million. The growth of the market can be attributed to growing research and development activities in the field of medical science which is resulting in the development of advanced life-saving medical equipment. Earlier, the pacemakers were large in size and also were bulky as compared to the pacemakers that are available in the market today. Over the years, with the advancements in technology, medical equipment organizations have introduced sophisticated pacemakers that are easy to manage and also have longer lifespan.
Get a sample brochure @ http://tinyurl.com/z5ss9mp Thrombectomy is the surgical removal of blood clot from a blood vessel. Venous thromboembolism (VTE) is a common lethal disease where blood clots within a vein. These clots can travel to arteries or veins in different parts of the body-brain, heart, kidneys, lungs, and limbs.